Teladoc (TDOC) Insider Files Sale of 16,787 Shares After Vesting

Rhea-AI Filing Summary

Teladoc Health (TDOC) filed a Form 144 reporting a proposed sale of 16,787 common shares held at Fidelity Brokerage Services with an aggregate market value of $127,435.15. The filing shows an approximate sale date of 09/11/2025 on the NYSE. The shares were acquired the prior day, 09/10/2025, through restricted stock vesting from the issuer and were granted as compensation. The filer reports no securities sold by the same person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Small insider sale following restricted stock vesting; transaction size appears immaterial to company capitalization.

The filing documents a routine disposition of recently vested restricted shares totaling 16,787 common shares valued at $127,435.15, executed through Fidelity and slated for the NYSE on 09/11/2025. The shares were acquired on 09/10/2025 as compensation, and there are no reported sales by the same person in the prior three months. This pattern—rapid sale after vesting—is common for employees or insiders managing personal liquidity and does not, by itself, indicate material corporate developments.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; includes customary representations and no recent sales to aggregate.

The Form 144 includes required elements: class of securities, broker details, number of shares, aggregate market value, acquisition method, and representation regarding material nonpublic information. The acquisition via restricted stock vesting and immediate proposed sale are documented, and the filer affirms no material undisclosed information. From a governance perspective, the filing appears compliant and procedural.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	16787	127435.15	176690662	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2025	Restricted Stock Vesting	Issuer			16787	09/10/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did TDOC report on this Form 144?

The filer reported a proposed sale of 16,787 common shares valued at $127,435.15, to be sold on the NYSE on 09/11/2025 through Fidelity Brokerage Services.

How were the TDOC shares acquired?

The shares were acquired on 09/10/2025 through restricted stock vesting from the issuer and were granted as compensation.

Were there other sales by the same person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker is handling the proposed sale?

The broker listed is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI.

Does the filer attest to possession of material nonpublic information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.